# The Effect of Alpha-lactalbumin on Microbiota Composition

> **NCT05674318** · NA · COMPLETED · sponsor: **Lo.Li.Pharma s.r.l** · enrollment: 10 (actual)

## Conditions studied

- Alpha-lactalbumin
- Microbiota
- Dysbiosis

## Interventions

- **DIETARY_SUPPLEMENT:** Alpha-lactalbumin

## Key facts

- **NCT ID:** NCT05674318
- **Lead sponsor:** Lo.Li.Pharma s.r.l
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-30
- **Primary completion:** 2023-09-30
- **Final completion:** 2023-11-30
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2024-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05674318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05674318, "The Effect of Alpha-lactalbumin on Microbiota Composition". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05674318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*